280 related articles for article (PubMed ID: 29031898)
21. Ginsenoside Rh1 potentiates dexamethasone's anti-inflammatory effects for chronic inflammatory disease by reversing dexamethasone-induced resistance.
Li J; Du J; Liu D; Cheng B; Fang F; Weng L; Wang C; Ling C
Arthritis Res Ther; 2014 May; 16(3):R106. PubMed ID: 24887434
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous quantification of twenty-one ginsenosides and their three aglycones in rat plasma by a developed UFLC-MS/MS assay: Application to a pharmacokinetic study of red ginseng.
Zhou QL; Zhu DN; Yang YF; Xu W; Yang XW
J Pharm Biomed Anal; 2017 Apr; 137():1-12. PubMed ID: 28086165
[TBL] [Abstract][Full Text] [Related]
23. Ginsenoside Rg1 exerts synergistic anti-inflammatory effects with low doses of glucocorticoids in vitro.
Song Y; Zhao F; Zhang L; Du Y; Wang T; Fu F
Fitoterapia; 2013 Dec; 91():173-179. PubMed ID: 24035860
[TBL] [Abstract][Full Text] [Related]
24. Production of ginsenoside aglycons and Rb1 deglycosylation pathway profiling by HPLC and ESI-MS/MS using Sphingobacterium multivorum GIN723.
Kim EM; Seo JH; Kim J; Park JS; Kim DH; Kim BG
Appl Microbiol Biotechnol; 2013 Sep; 97(18):8031-9. PubMed ID: 23812276
[TBL] [Abstract][Full Text] [Related]
25. Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor.
Lee YJ; Chung E; Lee KY; Lee YH; Huh B; Lee SK
Mol Cell Endocrinol; 1997 Oct; 133(2):135-40. PubMed ID: 9406859
[TBL] [Abstract][Full Text] [Related]
26. In vitro study of the relationship between the structure of ginsenoside and its antioxidative or prooxidative activity in free radical induced hemolysis of human erythrocytes.
Liu ZQ; Luo XY; Liu GZ; Chen YP; Wang ZC; Sun YX
J Agric Food Chem; 2003 Apr; 51(9):2555-8. PubMed ID: 12696936
[TBL] [Abstract][Full Text] [Related]
27. Ginsenosides are active ingredients in
You L; Cha S; Kim MY; Cho JY
J Ginseng Res; 2022 Nov; 46(6):711-721. PubMed ID: 36312737
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms.
King EM; Chivers JE; Rider CF; Minnich A; Giembycz MA; Newton R
PLoS One; 2013; 8(1):e53936. PubMed ID: 23349769
[TBL] [Abstract][Full Text] [Related]
29. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects.
Du J; Cheng B; Zhu X; Ling C
J Immunol; 2011 Jul; 187(2):942-50. PubMed ID: 21666059
[TBL] [Abstract][Full Text] [Related]
30. Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.
Robertson S; Allie-Reid F; Vanden Berghe W; Visser K; Binder A; Africander D; Vismer M; De Bosscher K; Hapgood J; Haegeman G; Louw A
J Biol Chem; 2010 Mar; 285(11):8061-75. PubMed ID: 20037160
[TBL] [Abstract][Full Text] [Related]
31. Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions.
Olaleye OE; Niu W; Du FF; Wang FQ; Xu F; Pintusophon S; Lu JL; Yang JL; Li C
Acta Pharmacol Sin; 2019 Jun; 40(6):833-849. PubMed ID: 30327544
[TBL] [Abstract][Full Text] [Related]
32. Ginsenosides in vascular remodeling: Cellular and molecular mechanisms of their therapeutic action.
Zhu GX; Zuo JL; Xu L; Li SQ
Pharmacol Res; 2021 Jul; 169():105647. PubMed ID: 33964471
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect.
Bae EA; Shin JE; Kim DH
Biol Pharm Bull; 2005 Oct; 28(10):1903-8. PubMed ID: 16204943
[TBL] [Abstract][Full Text] [Related]
34. Anti-inflammatory effects of ginsenoside Rg1 and its metabolites ginsenoside Rh1 and 20(S)-protopanaxatriol in mice with TNBS-induced colitis.
Lee SY; Jeong JJ; Eun SH; Kim DH
Eur J Pharmacol; 2015 Sep; 762():333-43. PubMed ID: 26054809
[TBL] [Abstract][Full Text] [Related]
35. Anti-stress effects of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol in immobilized mice.
Oh HA; Kim DE; Choi HJ; Kim NJ; Kim DH
Biol Pharm Bull; 2015; 38(2):331-5. PubMed ID: 25747994
[TBL] [Abstract][Full Text] [Related]
36. α Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes.
Zhao X; Khurana S; Charkraborty S; Tian Y; Sedor JR; Bruggman LA; Kao HY
J Biol Chem; 2017 Feb; 292(5):1637-1647. PubMed ID: 27998979
[TBL] [Abstract][Full Text] [Related]
37. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
38. Alteration of Panax ginseng saponin composition by overexpression and RNA interference of the protopanaxadiol 6-hydroxylase gene (CYP716A53v2).
Park SB; Chun JH; Ban YW; Han JY; Choi YE
J Ginseng Res; 2016 Jan; 40(1):47-54. PubMed ID: 26843821
[TBL] [Abstract][Full Text] [Related]
39. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury.
Lee HU; Bae EA; Han MJ; Kim NJ; Kim DH
Liver Int; 2005 Oct; 25(5):1069-73. PubMed ID: 16162168
[TBL] [Abstract][Full Text] [Related]
40. Ginsenoside Rg1 Acts as a Selective Glucocorticoid Receptor Agonist with Anti-Inflammatory Action without Affecting Tissue Regeneration in Zebrafish Larvae.
He M; Halima M; Xie Y; Schaaf MJM; Meijer AH; Wang M
Cells; 2020 Apr; 9(5):. PubMed ID: 32365641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
